ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 184 filers reported holding ARCUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $26 | -10.3% | 1,444 | 0.0% | 0.00% | – |
Q4 2022 | $29 | -100.0% | 1,444 | -71.2% | 0.00% | -100.0% |
Q2 2021 | $137,000 | -43.2% | 5,022 | -41.6% | 0.00% | 0.0% |
Q1 2021 | $241,000 | +249.3% | 8,598 | +223.2% | 0.00% | – |
Q4 2020 | $69,000 | +187.5% | 2,660 | +178.8% | 0.00% | – |
Q2 2020 | $24,000 | -42.9% | 954 | -68.5% | 0.00% | – |
Q1 2020 | $42,000 | -40.0% | 3,033 | -60.7% | 0.00% | – |
Q3 2019 | $70,000 | – | 7,708 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |